Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: The Effects of Device-guided Breathing Exercises on Blood Pressure in Patients With Hypertension [NA]
A completed clinical trial evaluated whether device-guided breathing exercises can reduce blood pressure in adults with hypertension. The st…
-
FDA approval · 2011-10-25FDA Approved: ATENOLOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Atenolol from Teva Pharmaceuticals USA, Inc. This action updates the regulatory status of the ge…
-
CLINICAL_TRIALS trial_result · 2011-10-21Clinical Trial Update: Fludrocortisone's Test in Salt Sensitivity [Phase 4]
A Phase 4 clinical trial update examining fludrocortisone as a test for salt sensitivity in hypertension.
-
CLINICAL_TRIALS trial_result · 2011-10-20Clinical Trial Update: The Effects of Lowering Dialysate Sodium in Hypertensive Hemodialysis Patients [NA]
A completed clinical trial evaluating the effects of lowering dialysate sodium in hypertensive patients undergoing hemodialysis.
-
CLINICAL_TRIALS research · 2011-10-20Clinical Trial Update: Finding Early Predictors of Myocardial Dysfunction in Patients With Hypertension
This clinical trial update discusses efforts to identify early predictors of myocardial dysfunction in patients with hypertension.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-10-19Clinical Trial Update: To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan Alone [Phase 4]
Phase 4 trial update showing non-inferiority of the amlodipine/valsartan combination to valsartan alone in treating hypertension.
-
FDA approval · 2011-10-18FDA Approved: ATENOLOL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for atenolol submitted by Aurobindo Pharma Limited, granting regulatory approval for the supplem…
-
FDA approval · 2011-10-17FDA Approved: PERINDOPRIL ERBUMINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for PERINDOPRIL ERBUMINE from Aurobindo Pharma Limited (ANDA) to market the generic product.
-
FDA approval · 2011-10-13FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for hydrochlorothiazide from Unichem Pharmaceuticals (USA), Inc., approving a generic hydrochlor…
-
CLINICAL_TRIALS trial_result · 2011-10-13Clinical Trial Update: The Metabolic Effects of Different Weight Loss Diets [NA]
This completed clinical trial evaluated the metabolic effects of different weight loss diets in individuals with metabolic syndrome, obesity…
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: B-type Natriuretic Peptide (BNP) in Human Hypertension [Phase 1]
A Phase 1 trial evaluating B-type natriuretic peptide for hypertension was terminated, representing a status update rather than a definitive…
-
FDA approval · 2011-10-12FDA Approved: ALISKIREN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for aliskiren hemifumarate from Prasco Laboratories.
-
CLINICAL_TRIALS research · 2011-10-03Clinical Trial Update: Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker [NA]
This clinical trial update describes changes after replacing ACE inhibitors with an angiotensin II receptor blocker in hypertension, with th…
-
CLINICAL_TRIALS trial_result · 2011-09-29Clinical Trial Update: Evaluation of Regional Myocardial Dynamics at Physical Stress in Essential Hypertension [NA]
This update concerns a clinical trial evaluating regional myocardial dynamics at physical stress in essential hypertension with left ventric…
-
CLINICAL_TRIALS trial_result · 2011-09-28Clinical Trial Update: Combined Renin Inhibition/Beta-blockade [NA]
The clinical trial evaluating combined renin inhibition with a beta-blocker for hypertension was terminated, with results posted in 2011.
-
FDA approval · 2011-09-27FDA Approved: PROCARDIA XL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for PROCARDIA XL (nifedipine) from Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2011-09-27Clinical Trial Update: Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension
A completed randomized trial compared an ACE inhibitor strategy with candesartan for the primary treatment of hypertension to reduce cardiov…
-
FDA approval · 2011-09-22FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
FDA approves a supplemental application for the spironolactone and hydrochlorothiazide combination from Prasco Laboratories. This action upd…
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed) [Phase 1]
This completed Phase 1 trial evaluated multiple doses of hydrochlorothiazide and isosorbide mononitrate on glucose homeostasis in hypertensi…
-
CLINICAL_TRIALS trial_result · 2011-09-22Clinical Trial Update: Study of 24 Hour Blood Pressure and the Association to Complications to Type 1 Diabetes
A completed study evaluated the association between 24-hour blood pressure and complications in people with Type 1 diabetes mellitus, includ…
-
FDA approval · 2011-09-21FDA Approved: TORSEMIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for torsemide from Teva Pharmaceuticals USA, Inc. This approval pertains to a supplemental submissio…
-
FDA approval · 2011-09-21FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for benazepril hydrochloride from Aurobindo Pharma Limited under the ANDA program.
-
CLINICAL_TRIALS safety_alert · 2011-09-20Clinical Trial Update: Atenolol Exposure as Risk for Adverse Metabolic Responses to Beta Blockers [NA]
A completed clinical trial evaluated whether atenolol exposure increases the risk of adverse metabolic responses when using beta blockers in…
-
CLINICAL_TRIALS trial_result · 2011-09-20Clinical Trial Update: INVEST: INternational VErapamil SR Trandolapril STudy [Phase 4]
Phase 4 INVEST study evaluating verapamil SR and trandolapril for hypertension and coronary artery disease has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-19Clinical Trial Update: Behavioural Treatment of Hypertension [NA]
This document indicates the completion of a clinical trial evaluating behavioral (non-pharmacologic) approaches to hypertension. The update …